Abstract
During their premenopausal years, women have a lower risk than men of getting cardiovascular disease. This protection continues after the menopause if women receive oestrogen replacement. Based on new experimental evidence we propose that some of the cardiovascular benefits of oestrogen replacement therapy may be due to a long-term calcium antagonist effect of oestrogen.
Original language | English |
---|---|
Pages (from-to) | 1264-1265 |
Number of pages | 2 |
Journal | Lancet |
Volume | 341 |
Issue number | 8855 |
DOIs | |
Publication status | Published - May 15 1993 |
ASJC Scopus subject areas
- Medicine(all)